Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:2289-2294
doi: 10.1161/hc4401.098294
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruygrok, P. N.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruygrok, P. N.
Right arrow Articles by Serruys, P. W.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow Chronic ischemic heart disease

(Circulation. 2001;104:2289.)
© 2001 American Heart Association, Inc.


Clinical Investigations and Reports

Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention

Peter N. Ruygrok, MBChB; Mark W.I. Webster, MBChB; Vincent de Valk, PhD; Gerrit-Anne van Es, PhD; John A. Ormiston, MBChB; Marie-Angèle M. Morel, BSc; Patrick W. Serruys, MD PhD

From Cardialysis, Westblaak 92, 3012 KM Rotterdam, Netherlands.

Correspondence to Peter Ruygrok, Cardiology Department, Green Lane Hospital, Private Bag 92-189, Green Lane West, Auckland, New Zealand. E-mail pruygrok{at}ahsl.co.nz

Background— Angiographic restenosis after percutaneous coronary interventional procedures is more common than recurrent angina. Clinical and angiographic factors associated with asymptomatic versus symptomatic restenosis after percutaneous coronary intervention were compared.

Methods and Results— All patients with angiographic restenosis from the BENESTENT I, BENESTENT II pilot, BENESTENT II, MUSIC, WEST 1, DUET, FINESS 2, FLARE, SOPHOS, and ROSE studies were analyzed. Multivariate analysis evaluated 46 clinical and angiographic variables, comparing those with and without angina. The 10 studies recruited 2690 patients who underwent percutaneous revascularization and 6-month follow-up angiography (86% of those eligible). Restenosis (>=50% diameter stenosis) occurred in 607 patients and was clinically silent in 335 (55%). Male sex (P=0.008), absence of antianginal therapy with nitrates (P=0.0002) and calcium channel blockers (P=0.02) at 6 months, greater reference diameter after the procedure (P=0.04), greater reference diameter at follow-up (P=0.004), and lesser lesion severity (percent stenosis) at 6 months (P=0.0004) were univariate predictors of asymptomatic restenosis. By multivariate analysis, only male sex (P=0.04), greater reference diameter at follow-up (P=0.002), and lesser lesion severity at 6 months (P=0.0001) were associated with restenosis without angina.

Conclusions— Approximately half of patients with angiographic restenosis have no symptoms. The only multivariate predictors of silent restenosis at 6 months were male sex, greater reference diameter at follow-up, and lesser lesion severity on follow-up angiography.


Key Words: angioplasty • restenosis • stents




This article has been cited by other articles:


Home page
JNMHome page
M. J. Zellweger, C. Kaiser, H. P. Brunner-La Rocca, P. T. Buser, S. Osswald, P. Weiss, J. Mueller-Brand, M. E. Pfisterer, and for the BASKET Investigators
Value and Limitations of Target-Vessel Ischemia in Predicting Late Clinical Events After Drug-Eluting Stent Implantation
J. Nucl. Med., April 1, 2008; 49(4): 550 - 556.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Karshovska, A. Zernecke, G. Sevilmis, A. Millet, M. Hristov, C. D. Cohen, H. Schmid, F. Krotz, H.-Y. Sohn, V. Klauss, et al.
Expression of HIF-1{alpha} in Injured Arteries Controls SDF-1{alpha} Mediated Neointima Formation in Apolipoprotein E Deficient Mice
Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2540 - 2547.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
K. M. Das, A. A. El-Menyar, A. M. Salam, R. Singh, W. A. K. Dabdoob, H. A. Albinali, and J. Al Suwaidi
Contrast-enhanced 64-Section Coronary Multidetector CT Angiography versus Conventional Coronary Angiography for Stent Assessment
Radiology, November 1, 2007; 245(2): 424 - 432.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kastrati, A. Dibra, J. Mehilli, S. Mayer, S. Pinieck, J. Pache, J. Dirschinger, and A. Schomig
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents
Circulation, May 16, 2006; 113(19): 2293 - 2300.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Kitta, T. Nakamura, Y. Kodama, H. Takano, K. Umetani, D. Fujioka, Y. Saito, K.-i. Kawabata, J.-e. Obata, Y. Ichigi, et al.
Endothelial Vasomotor Dysfunction in the Brachial Artery Is Associated With Late In-Stent Coronary Restenosis
J. Am. Coll. Cardiol., August 16, 2005; 46(4): 648 - 655.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Singh, B. J. Gersh, R. L. McClelland, K. K.L. Ho, J. T. Willerson, W. F. Penny, and D. R. Holmes Jr
Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial
J. Am. Coll. Cardiol., January 18, 2005; 45(2): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Z.H. Rittersma, R. J. de Winter, K. T. Koch, C. E. Schotborgh, M. Bax, G. S. Heyde, J. P. van Straalen, K. J. Mulder, J. G.P. Tijssen, G. T. Sanders, et al.
Preprocedural C-Reactive Protein Is Not Associated with Angiographic Restenosis or Target Lesion Revascularization after Coronary Artery Stent Placement
Clin. Chem., September 1, 2004; 50(9): 1589 - 1596.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K C Koch, W M Schaefer, K Ersahin, B Nowak, S Krueger, U Buell, P Hanrath, and R Hoffmann
Haemodynamic significance of stent lesions compared to native coronary lesions: a myocardial perfusion imaging study
Heart, June 1, 2004; 90(6): 691 - 692.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. N. Giedd and S. R. Bergmann
Myocardial perfusion imaging following percutaneous coronary intervention: the importance of restenosis, disease progression, and directed reintervention
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 328 - 336.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sakai, K. Mizuno, S. Yokoyama, J. Tanabe, T. Shinada, K. Seimiya, M. Takano, T. Ohba, M. Tomimura, R. Uemura, et al.
Morphologic changes in infarct-related plaque after coronary stent placement: A serial angioscopy study
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1558 - 1565.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. Zellweger, M. Weinbacher, A. W. Zutter, R. V. Jeger, J. Mueller-Brand, C. Kaiser, P. T. Buser, and M. E. Pfisterer
Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting
J. Am. Coll. Cardiol., July 2, 2003; 42(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Bergmann and K. N. Giedd
Silent ischemia: unsafe at any time
J. Am. Coll. Cardiol., July 2, 2003; 42(1): 41 - 44.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Y. Liu, A. K. Death, and D. J. Handelsman
Androgens and Cardiovascular Disease
Endocr. Rev., June 1, 2003; 24(3): 313 - 340.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. J. Drenth, N. J. G. M. Veeger, J. B. Winter, J. G. Grandjean, M. A. Mariani, A. d J. Boven van, and P. W. Boonstra
A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1955 - 1960.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. H. Shuhaiber, A. N. Evans, M. G. Massad, and A. S. Geha
Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery
Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 387 - 396.
[Abstract] [Full Text] [PDF]